Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylamine SCHEMBL5269402 | 0.97 | ALDH1A1 (0.37) | ALDH1A1TSHRFAAH | |
| Propylamine SCHEMBL1685468 | 0.88 | TSHR (0.36) | ALDH1A1TSHRFAAH | |
| Allylamine SCHEMBL3897770 | 0.84 | ALDH1A1 (0.60) | ALDH1A1TSHR | |
| SCHEMBL27922143 | 0.83 | TSHR (0.38) | ALDH1A1TSHR | |
| SCHEMBL22105 | 0.83 | — | — | |
| Alcohol SCHEMBL4539746 | 0.81 | TSHR (0.39) | ALDH1A1TSHRFAAH | |
| Ethyl Chloride SCHEMBL6536541 | 0.81 | TSHR (0.33) | ALDH1A1TSHRFAAH | |
| Diethylamine SCHEMBL27842865 | 0.81 | TP53 (0.50) | ALDH1A1TSHRFAAH | |
| Allylamine SCHEMBL3215908 | 0.81 | ALDH1A1 (0.56) | ALDH1A1TSHR | |
| Butane SCHEMBL4909113 | 0.81 | TSHR (0.40) | ALDH1A1TSHRFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4306566-B1 | CURABLE RESIN COMPOSITION, CURED PRODUCT AND ADHESIVE | ADEKA CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-12590178-B2 | Curable resin composition and method for suppressing curing shrinkage of curable resin composition | ADEKA CORPORATION (JP) | 2026-03-31 | — | — | US | disclosed |
| EP-4306567-B1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, AND ADHESIVE | ADEKA CORP (JP) | 2025-06-04 | — | — | EP | disclosed |
| US-12269917-B2 | Curable resin composition | ADEKA CORPORATION (JP) | 2025-04-08 | — | — | US | disclosed |
| US-20250109240-A1 | ONE-PACK TYPE EPOXY RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2025-04-03 | — | — | US | disclosed |
| US-20250109324-A1 | CURING AGENT FOR EPOXY RESIN, AND ADHESIVE | SUNSTAR ENGINEERING INC. (JP) | 2025-04-03 | — | — | US | disclosed |
| WO-2025062839-A1 | COMPOUND, EPOXY RESIN, CURABLE COMPOSITION, MATERIAL FOR RECYCLING, CURED ARTICLE, METHOD FOR PRODUCING CURED ARTICLE, METHOD FOR PRODUCING DECOMPOSITION PRODUCT, AND DECOMPOSITION METHOD | 株式会社ADEKA | 2025-03-27 | — | — | WO | disclosed |
| WO-2025047655-A1 | BLOCK URETHANE MATERIAL, COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND BLOCK URETHANE COMPOUND CONTAINED THEREIN | 株式会社ADEKA | 2025-03-06 | — | — | WO | disclosed |
| EP-4491653-A1 | ONE-PACK TYPE EPOXY RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2025-01-15 | — | — | EP | disclosed |
| US-20250002707-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, AND ADHESIVE | ADEKA CORPORATION (JP) | 2025-01-02 | — | — | US | disclosed |
| WO-2022168666-A1 | CURABLE RESIN COMPOSITION | 株式会社ADEKA | 2022-08-11 | — | — | WO | disclosed |
| WO-2022168670-A1 | CHARGE TRANSFER COMPLEX | 株式会社ADEKA | 2022-08-11 | — | — | WO | disclosed |
| WO-2022168665-A1 | NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND | 株式会社ADEKA | 2022-08-11 | — | — | WO | disclosed |
| EP-4029896-A1 | CURABLE RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2022-07-20 | — | — | EP | disclosed |
| US-20220185946-A1 | CURABLE RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2022-06-16 | — | — | US | disclosed |
| EP-3950761-A1 | CURABLE RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2022-02-09 | — | — | EP | disclosed |
| US-8911586-B2 | One liquid type cyanate-epoxy composite resin composition | ADEKA CORPORATION (JP) | 2014-12-16 | — | — | US | disclosed |
| US-20110095453-A1 | ONE LIQUID TYPE CYANATE-EPOXY COMPOSITE RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2011-04-28 | — | — | US | disclosed |
| US-5039648-A | Hydrogenating precipitate of cobalt salt and alkali metal carbonate; hydrogenation catalysts | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-08-13 | — | — | US | disclosed |
| US-4107308-A | HYPOTENSIVE AGENTS, HERBICIDES, REACTING SODIUM SALT WITH ALLYL OR ALKYL HALIDE, RING CLOSURE | AMERICAN CYANAMID COMPANY (US) | 1978-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590178-B2 | Curable resin composition and method for suppressing curing shrinkage of curable resin composition | SEM1, RER1, JMJD6 | ALDH1A1 1138/4885TSHR 2947/4885FAAH 2018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.